Navigation Links
Kylin Therapeutics Receives Notice of Allowance for Second U.S. Patent Covering Delivery of Therapeutic RNA and pRNAi Technology
Date:10/4/2011

WEST LAFAYETTE, Ind., Oct. 4, 2011 /PRNewswire/ -- Kylin Therapeutics, Inc., a leading second-generation RNAi company, announced today that it has received a notice of allowance from United States Patent and Trademark Office (USPTO) for its second U.S. patent application. This newly allowed patent broadly covers new therapeutic RNA technology, as well as expanded areas on Kylin's proprietary nanoparticle technology platform, "pRNA" ("packaging RNA"). This new intellectual property covers multi-valent RNA structures broadly encompassing: tissue targeting, aptamer binding, receptor-mediated endocytosis, and RNA interference. "We continue to be gratified that the USPTO recognizes pRNA as an entirely unique platform in the crowded RNAi intellectual property space," said J. Eric Davis, J.D., President and Chief Executive Officer of Kylin Therapeutics, Inc.

Upon issuance, this will be Kylin's second U.S. patent. Along with its other issued and granted pRNA patents in Europe, Australia, and the United States, Kylin believes that this seminal patent family represents rare "new ground" in the field of RNAi and the delivery of therapeutic RNA. Kylin has a total of five patent families, with several other applications in the pipeline. "The unexpected, pharmacologically robust nature of the pRNA platform continues to allow Kylin to claim more ground in areas such as RNAi and tissue-specific targeting," said Homer Pearce, Ph.D., Director and Chairman of Kylin's Scientific Advisory Board.

Kylin's pRNA intellectual property estate is based upon the innovative discoveries of Peixuan Guo, Ph.D., and others at Kylin, on the design and creation of novel, therapeutically relevant RNA molecules. These molecules can be engineered as RNA multiplexes that function as RNAi-inducing DICER substrates and tissue-targeting modalities, and they can be used systemically and discretely without additional delivery components. Kylin has continued and expanded upon the work of Dr. Gu
'/>"/>

SOURCE Kylin Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Skyline Diagnostics Establishes Research Collaboration With Janssen
2. Orexigen® Therapeutics Announces Multiple Contrave® Data Presentations at the 29th Annual Scientific Meeting of The Obesity Society
3. Halozyme Therapeutics to Present at the JMP Securities Healthcare Conference on September 28
4. ALS Therapy Development Institute and Aestus Therapeutics, Inc., Expand Collaboration on Development of Novel ALS Therapies
5. Healthpoint Biotherapeutics to Present at UBS Global Life Sciences Conference
6. PharmaVentures Engaged by Astex Therapeutics to Assist in the Divestment of US Facility
7. CMC Biologics Licenses Its CHEF1® Expression System to Oxford BioTherapeutics
8. Debiopharm and Ascenta Therapeutics, Inc. Announce An Exclusive License Agreement for the Development and Commercialization of the IAP (Inhibitor of Apoptosis Protein) Inhibitor AT-406 (Called Debio 1143 by Debiopharm) for the Treatment of Various T
9. FierceBiotech Names Pearl Therapeutics a 2011 Fierce 15 Biotech
10. Amsterdam Molecular Therapeutics Licenses Additional Novel Gene Therapy Vectors from National Institutes of Health
11. PTC Therapeutics and Genzyme Announce Restructuring of Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... interface is the device," Nobel laureate Herbert Kroemer ... be found at the junctures where layers of ... nanotechnology, the interfaces between layers of metal oxides ... high-tech favorites as spintronics, high-temperature superconductors, ferroelectrics and ...
(Date:1/15/2014)... January 15, 2014 The Pittcon Organizing Committee ... Food Safety Tech , an e-Journal and producer of ... agreement for the second year for the co-location of Food ... The partnership provides that the registration fee to attend the ...
(Date:1/15/2014)... January 15, 2014 Look inside the ... items for the lab, from fluid handling to instruments ... to ship when you order. , Preferred Solutions ... , from the L/S® model for precise flow control ...
(Date:1/15/2014)... and SAN JOSE, California , January 15, ... developing antibody-drug conjugates for cancer, today announced the appointment of ... Dr Reynolds has over 20 years, development experience gained in ... Seattle Genetics. "I am delighted to welcome Tom ...
Breaking Biology Technology:A deeper look at interfaces 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 2Oxford BioTherapeutics Appoints Thomas C Reynolds MD, PhD to its Board of Directors 3
... SAN FRANCISCO, July 20 Burrill & Company, a San ... Private Equity, Merchant Banking and Media, is pleased to announce that ... Director, for both Burrill & Company and Burrill Latin America. ... of Rio Bravo Venture Partners, an asset management firm created from ...
... BOZEN, Italy, July 20 Health ... with Charite-Universitatsmedizin,Berlin. Charite will install an i.v.STATION robot at ... The primary challenges in today,s ... time, waste, regulatory issues,lack of audit trails, motion injuries, ...
... , BASKING RIDGE, N.J., July ... the development of antithrombotic therapeutic aptamers with active control agents, ... Three new members (Dr. John Eikelboom of Canada, Dr. ... join the original members bringing the current size of the ...
Cached Biology Technology:Joao Paulo Baptista Joins Burrill & Company 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 2Health Robotics to Launch Germany's Installations of i.v.STATION(TM) at Charite-Universitatsmedizin Berlin 3Regado Biosciences Expands Medical Advisory Board 2Regado Biosciences Expands Medical Advisory Board 3Regado Biosciences Expands Medical Advisory Board 4
(Date:4/24/2014)... 2014GEN Publishing recently introduced Clinical OMICs ... the application of OMICs technologies in clinical settings. ... beginning to transform medical care just as they ... decade-and-a-half. , "GEN,s editors and reporters have written ... transcriptomics, etc. etc. for years," said John Sterling, ...
(Date:4/24/2014)... invented a simple and cheap way of making a ... a high-resolution microscope. , Costing less than a cent, ... in developing countries and remote areas. , The lens ... The Australian National University (ANU) Research School of Engineering, ... Institute of Medical Research to find ways to transform ...
(Date:4/24/2014)... North Carolina State University and the University of North ... device that could help identify arterial plaque that is ... attack or stroke. , At issue is the plaque ... types of plaque are deemed "vulnerable," meaning that they ... and cause heart attack or stroke. , "Existing state-of-the-art ...
Breaking Biology News(10 mins):Droplet lens 2New ultrasound device may add in detecting risk for heart attack, stroke 2
... Assistant Professor, Department of Microbiology & Immunology, University of ... with one of two 2012 Merck Irving S. Sigal ... scientists to recognize and award excellence in basic research ... memory of Irving S. Sigal, an instrumental figure in ...
... Kaye Wachsmuth, Ph.D., International Public Health Consultant, DeLand, ... Public Health Award. This award, established in honor ... who has exhibited exemplary leadership and service in ... award "for almost forty years of implementing state-of-the-art ...
... Talk about throwing yourself into a relationship too soon. A ... gets a whiff of female sex attractant, he,s quicker to start ... prematurely when he,s still too cool for powerful flight. So his ... race. The study illustrates the tradeoff between being quick to ...
Cached Biology News:The American Society for Microbiology honors Susan Sharp 2The American Society for Microbiology honors I. Kaye Wachsmuth 2The American Society for Microbiology honors I. Kaye Wachsmuth 3Virgin male moths think they're hot when they're not 2Virgin male moths think they're hot when they're not 3Virgin male moths think they're hot when they're not 4Virgin male moths think they're hot when they're not 5
12 breakable polypropylene strips of 8 wells each held in a rigid frame. Ideal for antibody assays....
... in vitro diagnostic assays, all EIA/RIA plates ... uniform binding, high optical clarity and low ... part of the Certified Surface Chemistry Programme, ... within QA release specifications. Linkage: This CLS ...
... Stabilizer is an aqueous solution that contains ... stabilizing chemicals in a saline solution, pH ... of 0.02% methylisothiazolone and 0.02% bromonitrodioxane as ... a diluent and stabilizer for biologically active ...
AC input: 230 V...
Biology Products: